Literature DB >> 23749546

Trials show delayed recurrence in ovarian cancer.

Eric Bender.   

Abstract

Phase I trials of 2 treatments for recurrent ovarian cancer-a 2-step immunotherapy treatment and an antibody-drug conjugate-demonstrated promising early results in delaying recurrence, in work presented at the American Association for Cancer Research Annual Meeting 2013.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23749546     DOI： 10.1158/2159-8290.CD-ND2013-013

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  5 in total

1.  CREB5 promotes tumor cell invasion and correlates with poor prognosis in epithelial ovarian cancer.

Authors:  Shanyang He; Yalan Deng; Yanbin Liao; Xiaojin Li; Jun Liu; Shuzhong Yao
Journal:  Oncol Lett       Date:  2017-10-20       Impact factor: 2.967

2.  Overexpression of glycosyltransferase 8 domain containing 2 confers ovarian cancer to CDDP resistance by activating FGFR/PI3K signalling axis.

Authors:  Shuting Huang; Suiying Liang; Guandi Chen; Jing Chen; Keli You; Haiyan Ye; Zhigang Li; Shanyang He
Journal:  Oncogenesis       Date:  2021-07-22       Impact factor: 7.485

3.  A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer.

Authors:  Eveline M Dijkgraaf; Saskia J A M Santegoets; An K L Reyners; Renske Goedemans; Hans W Nijman; Mariëtte I E van Poelgeest; Arien R van Erkel; Vincent T H B M Smit; Toos A H H Daemen; Jacobus J M van der Hoeven; Cornelis J M Melief; Marij J P Welters; Judith R Kroep; Sjoerd H van der Burg
Journal:  Oncotarget       Date:  2015-10-13

4.  The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.

Authors:  Shanyang He; Gang Niu; Jianhong Shang; Yalan Deng; Zhiyong Wan; Cai Zhang; Zeshan You; Hongwei Shen
Journal:  J Exp Clin Cancer Res       Date:  2017-10-04

5.  Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas.

Authors:  Chao Yang; Yanli Tan; Shouwei Li; Junhu Zhou; Qixue Wang; Yunfei Wang; Yingbin Xie; Luyue Chen; Jie Li; Chuan Fang; Chunsheng Kang
Journal:  Aging (Albany NY)       Date:  2019-12-10       Impact factor: 5.682
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.